NCT05099276View on ClinicalTrials.gov

Extended Postoperative Oral Tranexamic Acid in Knee Replacement

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

December 7, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

June 1, 2024

Conditions
Knee OsteoarthritisBlood LossPain, Postoperative
Interventions
DRUG

Tranexamic Acid Pill

1950 mg tranexamic acid (three capsules) given in post-anesthesia room and three capsules for postop day one and three capsules for postop day two

DRUG

Placebo

Three capsules of cellulose given in post-anesthesia room and three capsules for postop cay one and three capsules for postop day two

Trial Locations (1)

38138

Campbell Clinic, Germantown

All Listed Sponsors
lead

Campbell Clinic

OTHER

NCT05099276 - Extended Postoperative Oral Tranexamic Acid in Knee Replacement | Biotech Hunter | Biotech Hunter